Published in Int J Epidemiol on October 01, 1995
Long-term follow-up of patients with Crohn's disease treated with azathioprine or 6-mercaptopurine. Lancet (1996) 3.15
Clinical, biological, and endoscopic picture of attacks of Crohn's disease. Evolution on prednisolone. Groupe d'Etude Thérapeutique des Affections Inflammatoires Digestives. Gastroenterology (1990) 2.58
Paroxysmal nocturnal haemoglobinuria: long-term follow-up and prognostic factors. French Society of Haematology. Lancet (1996) 2.41
Gastrointestinal tolerability of meloxicam compared to diclofenac in osteoarthritis patients. International MELISSA Study Group. Meloxicam Large-scale International Study Safety Assessment. Br J Rheumatol (1998) 2.02
Expansion by folinic acid of the peripheral blood progenitor pool after chemotherapy: its use in autografting in acute leukaemia. Br J Haematol (1990) 2.02
A high serum concentration of interleukin-6 is predictive of relapse in quiescent Crohn's disease. Eur J Gastroenterol Hepatol (1997) 1.85
Oral mesalamine (Pentasa) as maintenance treatment in Crohn's disease: a multicenter placebo-controlled study. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID) Gastroenterology (1993) 1.71
Measurement of gastric emptying in dyspeptic patients: effect of a new gastrokinetic agent (cisapride). Gut (1985) 1.60
Survival and therapeutic modalities in patients with bone metastases of differentiated thyroid carcinomas. J Clin Endocrinol Metab (2001) 1.58
Role of adhesion molecules in the homing and mobilization of murine hematopoietic stem and progenitor cells. Blood (1998) 1.56
Anal lesions: any significant prognosis in Crohn's disease? Eur J Gastroenterol Hepatol (1997) 1.49
Three cases of typical aplastic anaemia associated with a Philadelphia chromosome. Br J Haematol (2001) 1.48
Ability of the American College of Rheumatology 1987 criteria to predict rheumatoid arthritis in patients with early arthritis and classification of these patients two years later. Arthritis Rheum (2001) 1.44
Improved cytogenetics in multiple myeloma: a study of 151 patients including 117 patients at diagnosis. Blood (1995) 1.39
Mesalazine as a maintenance treatment in Crohn's disease: is it the long awaited solution? Gut (1997) 1.38
High-dose methotrexate for the treatment of primary cerebral lymphomas: analysis of survival and late neurologic toxicity in a retrospective series. J Clin Oncol (1998) 1.37
Primary mediastinal large B-cell lymphoma. A clinicopathologic study of 141 cases compared with 916 nonmediastinal large B-cell lymphomas, a GELA ("Groupe d'Etude des Lymphomes de l'Adulte") study. Am J Surg Pathol (1996) 1.27
A controlled trial comparing ciprofloxacin with mesalazine for the treatment of active Crohn's disease. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID). Am J Gastroenterol (1999) 1.27
Epidemiology of aplastic anemia in France: a prospective multicentric study. The French Cooperative Group for Epidemiological Study of Aplastic Anemia. Blood (1990) 1.20
Prolonged immune deficiency following allogeneic stem cell transplantation: risk factors and complications in adult patients. Br J Haematol (2001) 1.19
Successive treatment with cyclosporine and infliximab in steroid-refractory ulcerative colitis. Am J Gastroenterol (2011) 1.09
Comparison of weight- and height-based indices for assessing the risk of death in severely malnourished children. Am J Epidemiol (1996) 1.03
A model to standardise mortality of severely malnourished children using nutritional status on admission to therapeutic feeding centres. Eur J Clin Nutr (1997) 1.01
Aggressive lymphomas with renal involvement: a study of 48 patients treated with the LNH-84 and LNH-87 regimens. Groupe d'Etude des Lymphomes de l'Adulte. Br J Cancer (1994) 1.01
Mesalamine in Crohn's disease with steroid-induced remission: effect on steroid withdrawal and remission maintenance, Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives. Gastroenterology (1996) 1.00
Effects of cholecystokinin and metoclopramide on jejunal movements of water and electrolytes and on transit time of luminal fluid in man. Eur J Clin Invest (1972) 0.96
Prognostic factors and evolution of acquired aplastic anemia in childhood. A prospective analysis of 48 androgen-treated cases. Am J Pediatr Hematol Oncol (1982) 0.89
Health and functional status of adult recipients 1 year after allogeneic haematopoietic stem cell transplantation. Br J Haematol (2001) 0.88
Recovery of CFU-GM from cryopreserved marrow and in vivo evaluation after autologous bone marrow transplantation are predictive of engraftment. Exp Hematol (1986) 0.88
A convenient source of CFU-s inhibitors: the fetal calf liver. Cell Tissue Kinet (1984) 0.88
Protection of mice against lethal doses of 1 beta-D-arabinofuranosylcytosine by pluripotent stem cell inhibitors. Cancer Res (1982) 0.86
Drug use and aplastic anaemia: the French experience. French Cooperative Group for the Epidemiological Study of Aplastic Anaemia. Eur J Haematol Suppl (1996) 0.86
[Factors related to 30th day mortality in upper digestive tract hemorrhage in cirrhotic patients (author's transl)]. Gastroenterol Clin Biol (1980) 0.84
Effects of synthetic human gastrin I on movements on water, electrolytes, and glucose across the human small intestine. Gastroenterology (1976) 0.84
Further studies on prostaglandin E1-induced jejunal secretion of water and electrolytes in man, with special reference to the influence of ethacrynic acid, furosemide, and aspirin. Gastroenterology (1976) 0.84
Down modulation of TNF-alpha mRNA placental expression by AZT used for the prevention of HIV-1 mother-to-child transmission. Placenta (2005) 0.83
Gastrin cell distribution in normal human stomachs and in patients with Zollinger-Ellison syndrome. Gastroenterology (1978) 0.83
Incubation time for AIDS from French transfusion-associated cases. Nature (1989) 0.83
Effect of feeding yogurt versus milk in children with persistent diarrhea. J Pediatr Gastroenterol Nutr (1990) 0.83
[Effect of prostaglandin E 1 on transit time and net and unidirectional movements of water and electrolytes in the human jejunum]. Biol Gastroenterol (Paris) (1972) 0.82
Adult patients presenting with pancytopenia: a reappraisal of underlying pathology and diagnostic procedures in 213 cases. Hematol Pathol (1989) 0.82
Global and partial agreement among several observers. Stat Med (1998) 0.82
Upper digestive tract hemorrhage in cirrhotic patients. Contribution of multidimensional analysis to the study of variables related to the cause of the hemorrhage. Dig Dis Sci (1981) 0.81
Normal human granulopoiesis revisited. II. Bone marrow data. Biomed Pharmacother (1985) 0.81
Effect of pentagastrin upon movements of water, electrolytes and glucose across the human jejunum and ileum. Digestion (1973) 0.80
Autologous bone marrow transplantation using marrow incubated with Asta Z 7557 in adult acute leukemia. Blood (1986) 0.80
Primary lymphoma of bone: a prospective study of 28 cases. Joint Bone Spine (2000) 0.80
Cell cycle models and mother-daughter correlation. J Theor Biol (1988) 0.79
The tetrapeptide AcSerAspLysPro (Seraspenide), a hematopoietic inhibitor, may reduce the in vitro toxicity of 3'-azido-3'-deoxythymidine to human hematopoietic progenitors. Stem Cells (1993) 0.79
Leukemic CD3+ LGL share functional properties with their CD8+ CD57+ cell counterpart expanded after BMT. Leukemia (1999) 0.79
Gestational age determination and prevention of HIV perinatal transmission. Int J Gynaecol Obstet (2005) 0.79
[Hypocalcemia caused by hypomagnesemia during a treatment with cisplatin]. Rev Med Interne (1996) 0.79
Osteoporosis in inflammatory bowel disease: effect of calcium and vitamin D with or without fluoride. Aliment Pharmacol Ther (2002) 0.78
Mathematical analysis of bone marrow erythropoiesis: application to C3H mouse data. Blood Cells (1980) 0.78
Why still prescribe chloramphenicol in 1983? Comparison of the clinical and biological hematologic effects of chloramphenicol and thiamphenicol. Blut (1983) 0.78
Soluble interleukin-2 receptor in Crohn's disease. Assessment of disease activity and prediction of relapse. Dig Dis Sci (1995) 0.78
Interleukin 2 interacts with myeloid growth factors in serum-free long-term bone marrow culture. Br J Haematol (1994) 0.77
[4 cases of acquired Willebrand factor deficiency associated with monoclonal dysglobulinemia]. Ann Med Interne (Paris) (1983) 0.77
Pulmonary toxicity of chemotherapy and G/GM-CSF: a report of five cases. Respir Med (1999) 0.77
[Intestinal absorption of vitamin D, linoleic acid and cholesterol from micellar solutions: study in normal humans by the "in situ" perfusion method]. Biol Gastroenterol (Paris) (1976) 0.77
Risk factors for fatal diarrhoea among dehydrated malnourished children in a Madagascar hospital. Eur J Clin Nutr (1995) 0.77
Inhibition of human bone marrow progenitors by the synthetic tetrapeptide AcSDKP. Exp Hematol (1990) 0.77
Modifications of hemato-biological parameters in pregnant women in a migrating population in northern Cameroon: prevalence of anemia, iron and folates deficiencies. Int J Vitam Nutr Res (1987) 0.77
Cyclosporin A as a modifier agent in the salvage treatment of acute leukemia (AL). Leukemia (1993) 0.76
[Is the dilution of milk necessary in benign acute diarrhea in eutrophic infants?]. Arch Fr Pediatr (1989) 0.76
Soluble CD16 (sCD16), a marker of malignancy in individuals with monoclonal gammopathy of undetermined significance (MGUS). Br J Haematol (1996) 0.76
Normal human granulopoiesis revisited. I. Blood data. Biomed Pharmacother (1984) 0.76
[Clinical consequences of replacing milk with yogurt in persistent infantile diarrhea]. Ann Pediatr (Paris) (1992) 0.76
[Adult T-cell leukemia and non-malignant adenopathies associated with HTLV I virus. Apropos of 17 patients born in the Caribbean region and Africa]. Presse Med (1990) 0.76
In vivo protection of normal mouse hematopoiesis by a beta 2 blocking agent during S-phase chemotherapy. Cancer Res (1984) 0.76
T-cell lymphoma with eosinophilia of donor origin occurring 12 years after allogeneic bone marrow transplantation for myeloma. Transplantation (2001) 0.75
[Maintenance treatment of Crohn's disease using orally administered mesalazine (Pentasa). A controlled multicenter study. The Study Groups on the Treatment of Inflammatory Digestive Disorders]. Ann Gastroenterol Hepatol (Paris) (1993) 0.75
Evaluation of a model to predict recurrence after radical cystectomy in bilharzial bladder cancer patients. Br J Cancer (1989) 0.75
Calprotectin and IBD. Gut (2005) 0.75
Establishment of a reliable experimental procedure for bone marrow purging with mafosfamide (ASTA Z 7557). Exp Hematol (1989) 0.75
Clonogenic leukemic progenitor cells in acute myelocytic leukemia are highly sensitive to cryopreservation: possible purging effect for autologous bone marrow transplantation. Bone Marrow Transplant (1991) 0.75
[Leukocyte differential of the Coulter VCS. Evaluation and modalities of use in comparison with the Coulter STKR and manual count]. Ann Biol Clin (Paris) (1990) 0.75
Risk factors for A.I.D.S. among homosexual men in France. Eur J Epidemiol (1988) 0.75
Long-term effects of high doses of cytosine arabinoside on pluripotent stem cells (CFU-S). Exp Hematol (1989) 0.75
Automatic search for model to simulate the differentiation of T lymphocytes within the thymus. Acta Biotheor (1992) 0.75
The mixed epidermal cell lymphocyte-reaction is the most predictive factor of acute graft-versus-host disease in bone marrow graft recipients. Br J Haematol (1988) 0.75
Power calculation for the likelihood ratio-test when comparing two dependent intraclass correlation coefficients. Comput Methods Programs Biomed (2005) 0.75
Presence of elevated serum interleukin-2 levels in pregnant women. N Engl J Med (1990) 0.75
[Meningo-encephalic localizations of non-hodgkinian lymphomas and Waldenstrom's macroglobulinemia]. Ann Med Interne (Paris) (1977) 0.75
Difference in kinetics of hematopoietic reconstitution between ALL and ANLL after autologous bone marrow transplantation with marrow treated in vitro with mafosfamide (ASTA Z 7557). Bone Marrow Transplant (1987) 0.75
[Mixed lympho-epidermal cell cultures: value in bone marrow grafts]. Presse Med (1989) 0.75
A French cluster of Creutzfeldt-Jakob disease: a molecular analysis. Eur J Neurol (2002) 0.75
Revisiting statistical methods to assess the effect of hematopoietic inhibitors using colony-forming assays. Ann N Y Acad Sci (1991) 0.75
Towards an objective prognostic index of acute graft-versus-host disease. Anal Cell Pathol (1993) 0.75
Conditions of validation and use of the screening method for vaccine efficacy evaluation. Rev Epidemiol Sante Publique (1993) 0.75
Is P50 the most representative P(SO2) to evaluate HbO2 affinity? Scand J Clin Lab Invest Suppl (1990) 0.75
[Effect of pentagastrin on intestinal absorption in man]. Biol Gastroenterol (Paris) (1971) 0.75
In vitro purging of bone marrow with mafosfamide synergizes with in vivo chemotherapy to delay the hematological recovery in a murine model of autologous bone marrow transplantation. Exp Hematol (1993) 0.75